The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2590-0048
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities ; day:8 ; month:7 ; year:2022 ; pages:1-14
Clinical hematology international ; (8.7.2022), 1-14
- Urheber
-
Ellard, Rose
Kenyon, Michelle
Hutt, Daphna
Aerts, Erik
Ruijter, Maaike de
Chabannon, Christian
Mohty, Mohamad
Montoto, Silvia
Wallhult, Elisabeth
Murray, John
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s44228-022-00004-8
- URN
-
urn:nbn:de:101:1-2022083021392333772049
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ellard, Rose
- Kenyon, Michelle
- Hutt, Daphna
- Aerts, Erik
- Ruijter, Maaike de
- Chabannon, Christian
- Mohty, Mohamad
- Montoto, Silvia
- Wallhult, Elisabeth
- Murray, John
- SpringerLink (Online service)
Ähnliche Objekte (12)
Another Year to Celebrate Advances in Clinical Hematology
‘Standing on the Shoulders of the Giants’: Dr. Giampaolo Merlini
One Year into the COVID-19 Pandemic
‘Standing on the Shoulders of the Giants’: Dr. Robert Kyle
‘Standing on the Shoulders of the Giants’: Dr Rainer Storb
Looking Ahead: Clinical Hematology International Turns One
Clinical Hematology International: Why a New Journal in Hematology?
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
A roadmap towards improving outcomes in multiple myeloma
CART Cell Toxicities: New Insight into Mechanisms and Management
Another Year to Celebrate Advances in Clinical Hematology
‘Standing on the Shoulders of the Giants’: Dr. Giampaolo Merlini
One Year into the COVID-19 Pandemic
‘Standing on the Shoulders of the Giants’: Dr. Robert Kyle
‘Standing on the Shoulders of the Giants’: Dr Rainer Storb
Looking Ahead: Clinical Hematology International Turns One
Clinical Hematology International: Why a New Journal in Hematology?
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
A roadmap towards improving outcomes in multiple myeloma
CART Cell Toxicities: New Insight into Mechanisms and Management
Another Year to Celebrate Advances in Clinical Hematology
‘Standing on the Shoulders of the Giants’: Dr. Giampaolo Merlini
One Year into the COVID-19 Pandemic
‘Standing on the Shoulders of the Giants’: Dr. Robert Kyle
‘Standing on the Shoulders of the Giants’: Dr Rainer Storb
Looking Ahead: Clinical Hematology International Turns One
Clinical Hematology International: Why a New Journal in Hematology?
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
A roadmap towards improving outcomes in multiple myeloma